4 Undervalued Pharmaceuticals Stocks for Tuesday, October 01
Discover the top 4 undervalued Pharmaceuticals stocks for Tuesday, October 01 based on AAII’s Stock Grades.Omar Beirat
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Omar Beirat
Omar Beirat
Jack Gilleland
Jenna Brashear
Jenna Brashear
| Share Statistics | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $54,492.9 | $569.9 | 94% |
|
| Shares Out (Mil) | 1,132.7 | 44.8 | 95% |
|
| Institutional Ownership | 50.0% | 84.6% | 30% |
|
| Float (Mil) | 982.4 | 45.1 | 91% |
|
| Beta | 0.84 | 0.67 | 50% |
|
| Avg Daily Volume (000s) | 762 | 294 | 66% |
|
| Price Change (52-week) |
70.4% | 65.2% | 87% |
|
| Growth | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.1% | 6.7% | 20% |
|
| Net Income (5yr) | 19.8% | (2.0%) | 73% |
|
| EPS (5yr) | 19.8% | 14.9% | 67 |
|
| Dividends (5yr) | (44.5%) | 0.0% | 58% |
|
| Cash Flow (5yr) | (13.8%) | (14.9%) | 56% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 2 | 2 | |
| Current EPS | $0.255 | $1.158 | $1.239 | |
| Month Ago EPS | $0.898 | $5.086 | $5.384 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $1.027 | $4.899 | $5.459 | |
| Year/Year Chg | na | (126.8%) | (132.5%) | |
| Financials | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $52,164 | $230 | 97% |
|
| Net Income (TTM) (Mil) | ($2,486) | ($11) | 0% |
|
| EPS (TTM) | ($2.530) | ($0.600) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | $5,939 | ($6) | 96% |
|
| Net Cash Flow (TTM) (Mil) | $2,051 | $4 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $35,379 | $7 | 97% |
|
| Enterprise Value (Q1) (Mil) | $80,303 | $493 | 95% |
|
| Valuation | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.89 | na |
|
| P/E | na | 20.6 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 59.9% | 65.9% | 73% |
|
| Net Margin | (4.8%) | (0.2%) | 25% |
|
| ROA | (2.1%) | (25.5%) | 34% |
|
| ROE | (7.3%) | (21.4%) | 29% |
|
| Liabilities to Assets | 73.2% | 35.5% | 68% |
|
| F-Score | na | 3 | na |
|
Bayer Aktiengesellschaft did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors